Lyra Therapeutics Inc.

0.20
-0.01 (-6.54%)
At close: Mar 03, 2025, 3:59 PM
0.19
-1.18%
After-hours: Mar 03, 2025, 04:00 PM EST

Lyra Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 22.35M 32.55M 45.75M 74.59M 9.81M 23.89M
Short-Term Investments 80.4M 65.34M n/a n/a n/a n/a
Long-Term Investments n/a 1.39M 329K 329K 329K 329K
Other Long-Term Assets 2.5M 3.28M 762K 118K 1.1M n/a
Receivables n/a n/a n/a n/a n/a 167K
Inventory n/a n/a n/a n/a n/a 1.00
Other Current Assets 2.07M 2.94M 4.34M 2.65M 311K 872K
Total Current Assets 104.82M 100.83M 47.92M 75.92M 10.12M 24.93M
Property-Plant & Equipment 35.28M 4.47M 5.86M 4.47M 3.42M 103K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 37.78M 9.14M 6.95M 4.91M 4.84M 432K
Total Assets 142.6M 109.97M 54.87M 80.83M 14.96M 25.36M
Account Payables 3.13M 2.62M 3.13M 922K 1.07M 631K
Deferred Revenue 1.66M 1.27M 9.79M 2.83M 3.13M n/a
Short-Term Debt 8.91M 3.51M 2.15M 1.97M 899K n/a
Other Current Liabilities 9.37M 9.03M 3.18M 1.99M 3.24M 1.33M
Total Current Liabilities 19.6M 14.47M 18.25M 4.88M 5.21M 1.96M
Long-Term Debt 21.45M 667K 379K 1.45M 2.43M n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a 130.47M
Total Long-Term Liabilities 33.58M 14.74M 2.31M 1.45M 2.43M 130.47M
Total Liabilities 53.18M 29.21M 20.55M 6.34M 7.63M 132.43M
Total Debt 26.88M 2.22M 1.45M 2.44M 3.33M n/a
Common Stock 57K 32K 13K 13K 6K 6K
Retained Earnings -311.36M -248.68M -193.4M -149.88M -127.76M -111.45M
Comprehensive Income 33K 10K n/a -80.83M 0.00 -2.8M
Shareholders Equity 89.42M 80.75M 34.32M 74.49M 7.33M -107.07M
Total Investments 80.4M 65.34M 329K 329K 329K 329K